RWP
GSK icon

RWA Wealth Partners’s GSK GSK Stock Holding History

RWA Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,480
Closed -$125K – 436
2018
Q2 		$125K Buy
2,480
+80
+3% +$4.03K 0.01% 287
2018
Q1 		$117K Buy
+2,400
New +$112K 0.02% 249
2017
Q4 		– Sell
-10,459
Closed -$531K – 240
2017
Q3 		$531K Buy
+10,459
New +$531K 0.06% 154

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

RWA Wealth Partners's GSK Position: Q3 2018 in Review

RWA Wealth Partners sold out of GSK (GSK) in Q3 2018, closing a stake of 2,480 shares — an estimated $125K sold.

RWA Wealth Partners first reported a position in GSK in Q3 2017 and held it in 3 quarters. The position peaked at $531K in Q3 2017. 787 funds tracked by Wall St. Rank hold GSK as of Q3 2018.

  • RWA Wealth Partners reported no remaining GSK position as of Q3 2018 after selling out during the quarter.
  • RWA Wealth Partners sold 2,480 GSK shares in Q3 2018, an estimated $125K.
  • RWA Wealth Partners first reported a position in GSK in Q3 2017 and held it in 3 quarters.
  • RWA Wealth Partners's GSK position peaked at $531K in Q3 2017.
  • 787 funds tracked by Wall St. Rank held GSK as of Q3 2018.

Based on RWA Wealth Partners's 13F filing for Q3 2018, filed 14 Nov 2018.